Baotou Dongbao Bio-Tech Co.,Ltd (SHE:300239)
China · Delayed Price · Currency is CNY 5.36
-0.20 (-3.60%)
Apr 10, 2026, 9:25 AM CST
SHE:300239 Revenue
In the year 2025, Baotou Dongbao Bio-Tech Co.,Ltd had annual revenue of 745.31M CNY, down -15.78%. Baotou Dongbao Bio-Tech Co.,Ltd had revenue of 212.51M in the quarter ending December 31, 2025, a decrease of -15.61%.
Revenue
745.31M
Revenue Growth
-15.78%
P/S Ratio
4.19
Revenue / Employee
538.13K
Employees
1,385
Market Cap
3.13B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 745.31M | -139.62M | -15.78% |
| Dec 31, 2024 | 884.93M | -89.58M | -9.19% |
| Dec 31, 2023 | 974.51M | 31.12M | 3.30% |
| Jan 1, 2023 | 943.40M | 331.23M | 54.11% |
| Jan 1, 2022 | 612.17M | 163.34M | 36.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Anhui Fengyuan Pharmaceutical | 4.15B |
| Nanjing Well Pharmaceutical Group | 1.31B |
| Hunan Hansen Pharmaceutical | 1.05B |
| Anhui Sunhere Pharmaceutical Excipients | 934.72M |
| Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD | 886.96M |
| ShanXi C&Y Pharmaceutical Group Co.,LTD. | 849.26M |
| Zhejiang Shengda Bio-Pharm | 839.82M |
| Jiangxi Synergy Pharmaceutical | 825.20M |